We exploited high-throughput data analysis methods and databases to elucidate novel ESCC prognostic biomarkers and constructed an immune-related prognostic signature based on CCR5 and TSPAN2. This evidence concerns the gene CCR5 and esophageal squamous cell carcinoma.